메뉴 건너뛰기




Volumn 157, Issue 6, 2007, Pages 1183-1188

Reduction of immunosuppression for transplant-associated skin cancer: Thresholds and risks

Author keywords

Allograft compromise; Immunosuppression; Skin cancer; Transplant

Indexed keywords

CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RAPAMYCIN;

EID: 36148934968     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08203.x     Document Type: Article
Times cited : (31)

References (32)
  • 1
    • 0036657493 scopus 로고    scopus 로고
    • Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management
    • Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002 47 : 1 17.
    • (2002) J Am Acad Dermatol , vol.47 , pp. 1-17
    • Berg, D.1    Otley, C.C.2
  • 2
    • 0037464506 scopus 로고    scopus 로고
    • Skin cancers after organ transplantation
    • Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003 348 : 1681 91.
    • (2003) N Engl J Med , vol.348 , pp. 1681-91
    • Euvrard, S.1    Kanitakis, J.2    Claudy, A.3
  • 3
    • 0037341914 scopus 로고    scopus 로고
    • Defining the clinical course of metastatic skin cancer in organ transplant recipients: A multicenter collaborative study
    • Martinez JC, Otley CC, Stasko T et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003 139 : 301 6.
    • (2003) Arch Dermatol , vol.139 , pp. 301-6
    • Martinez, J.C.1    Otley, C.C.2    Stasko, T.3
  • 4
    • 0033560767 scopus 로고    scopus 로고
    • Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience
    • Veness MJ, Quinn DI, Ong CS et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999 85 : 1758 64.
    • (1999) Cancer , vol.85 , pp. 1758-64
    • Veness, M.J.1    Quinn, D.I.2    Ong, C.S.3
  • 5
    • 0027515923 scopus 로고
    • De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation
    • Sheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993 25 : 1383 4.
    • (1993) Transplant Proc , vol.25 , pp. 1383-4
    • Sheil, A.G.1    Disney, A.P.2    Mathew, T.H.3    Amiss, N.4
  • 6
    • 0032973963 scopus 로고    scopus 로고
    • Skin cancer in Australian heart transplant recipients
    • Ong CS, Keogh AM, Kossard S et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999 40 : 27 34.
    • (1999) J Am Acad Dermatol , vol.40 , pp. 27-34
    • Ong, C.S.1    Keogh, A.M.2    Kossard, S.3
  • 7
    • 0029097249 scopus 로고
    • Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: A double-blind, placebo-controlled study
    • Bavinck JN, Tieben LM, Van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995 13 : 1933 8.
    • (1995) J Clin Oncol , vol.13 , pp. 1933-8
    • Bavinck, J.N.1    Tieben, L.M.2    Van Der Woude, F.J.3
  • 8
    • 15044345553 scopus 로고    scopus 로고
    • Reduction of immunosuppression for transplant-associated skin cancer: Rationale and evidence of efficacy
    • Otley CC, Maragh SL. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. Dermatol Surg 2005 31 : 163 8.
    • (2005) Dermatol Surg , vol.31 , pp. 163-8
    • Otley, C.C.1    Maragh, S.L.2
  • 9
    • 0036097712 scopus 로고    scopus 로고
    • Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression
    • Duman S, Toz H, Asci G et al. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Nephrol Dial Transplant 2002 17 : 892 6.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 892-6
    • Duman, S.1    Toz, H.2    Asci, G.3
  • 10
    • 0035025775 scopus 로고    scopus 로고
    • Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients
    • Tsai DE, Hardy CL, Tomaszewski JE et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 2001 71 : 1076 88.
    • (2001) Transplantation , vol.71 , pp. 1076-88
    • Tsai, D.E.1    Hardy, C.L.2    Tomaszewski, J.E.3
  • 11
    • 0035678741 scopus 로고    scopus 로고
    • Controlling the incidence of infection and malignancy by modifying immunosuppression
    • Soulillou JP, Giral M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 2001 72 (Suppl. 12 S89 93.
    • (2001) Transplantation , vol.72 , Issue.12
    • Soulillou, J.P.1    Giral, M.2
  • 12
    • 0032574187 scopus 로고    scopus 로고
    • Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens
    • Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998 351 : 623 8.
    • (1998) Lancet , vol.351 , pp. 623-8
    • Dantal, J.1    Hourmant, M.2    Cantarovich, D.3
  • 13
    • 0035051159 scopus 로고    scopus 로고
    • Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants
    • Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001 137 : 459 63.
    • (2001) Arch Dermatol , vol.137 , pp. 459-63
    • Otley, C.C.1    Coldiron, B.M.2    Stasko, T.3    Goldman, G.D.4
  • 14
    • 1942508212 scopus 로고    scopus 로고
    • Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma
    • Moloney FJ, Kelly PO, Kay EW et al. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol Surg 2004 30 : 674 8.
    • (2004) Dermatol Surg , vol.30 , pp. 674-8
    • Moloney, F.J.1    Kelly, P.O.2    Kay, E.W.3
  • 15
    • 0033007170 scopus 로고    scopus 로고
    • Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
    • Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999 40 : 177 86.
    • (1999) J Am Acad Dermatol , vol.40 , pp. 177-86
    • Jensen, P.1    Hansen, S.2    Moller, B.3
  • 16
    • 0343852703 scopus 로고    scopus 로고
    • Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients
    • Glover MT, Deeks JJ, Raftery MJ et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997 349 : 398.
    • (1997) Lancet , vol.349 , pp. 398
    • Glover, M.T.1    Deeks, J.J.2    Raftery, M.J.3
  • 17
    • 0028244603 scopus 로고
    • Triple therapy and incidence of de novo cancer in renal transplant recipients
    • Kehinde EO, Petermann A, Morgan JD et al. Triple therapy and incidence of de novo cancer in renal transplant recipients. Br J Surg 1994 81 : 985 6.
    • (1994) Br J Surg , vol.81 , pp. 985-6
    • Kehinde, E.O.1    Petermann, A.2    Morgan, J.D.3
  • 18
    • 0024521962 scopus 로고
    • Epidermal dysplasia and cyclosporine therapy in renal transplant patients: A comparison with azathioprine
    • Shuttleworth D, Marks R, Griffin PJ, Salaman JR. Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine. Br J Dermatol 1989 120 : 551 4.
    • (1989) Br J Dermatol , vol.120 , pp. 551-4
    • Shuttleworth, D.1    Marks, R.2    Griffin, P.J.3    Salaman, J.R.4
  • 19
    • 0030962571 scopus 로고    scopus 로고
    • Malignancy after renal transplantation: Analysis of incidence and risk factors in 1 700 patients followed during a 25-year period
    • Hiesse C, Rieu P, Kriaa F et al. Malignancy after renal transplantation: analysis of incidence and risk factors in 1 700 patients followed during a 25-year period. Transplant Proc 1997 29 : 831 3.
    • (1997) Transplant Proc , vol.29 , pp. 831-3
    • Hiesse, C.1    Rieu, P.2    Kriaa, F.3
  • 20
    • 0034235161 scopus 로고    scopus 로고
    • Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients
    • Ramsay HM, Fryer AA, Reece S et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000 36 : 167 76.
    • (2000) Am J Kidney Dis , vol.36 , pp. 167-76
    • Ramsay, H.M.1    Fryer, A.A.2    Reece, S.3
  • 21
    • 0033999806 scopus 로고    scopus 로고
    • Skin cancer in heart transplant recipients: Frequency and risk factor analysis
    • Fortina AB, Caforio AL, Piaserico S et al. Skin cancer in heart transplant recipients: frequency and risk factor analysis. J Heart Lung Transplant 2000 19 : 249 55.
    • (2000) J Heart Lung Transplant , vol.19 , pp. 249-55
    • Fortina, A.B.1    Caforio, A.L.2    Piaserico, S.3
  • 22
    • 0000716939 scopus 로고    scopus 로고
    • Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
    • Gjersvik P, Hansen S, Moller B et al. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transpl Int 2000 13 (Suppl. 1 S380 1.
    • (2000) Transpl Int , vol.13 , Issue.1
    • Gjersvik, P.1    Hansen, S.2    Moller, B.3
  • 23
    • 21644437017 scopus 로고    scopus 로고
    • Strategies for minimizing immunosuppression in kidney transplantation
    • Kirk AD, Mannon RB, Swanson SJ, Hale DA. Strategies for minimizing immunosuppression in kidney transplantation. Transpl Int 2005 18 : 2 14.
    • (2005) Transpl Int , vol.18 , pp. 2-14
    • Kirk, A.D.1    Mannon, R.B.2    Swanson, S.J.3    Hale, D.A.4
  • 24
    • 33644899100 scopus 로고    scopus 로고
    • Reduction of Immunosuppression Task Force of the International Transplant Skin Cancer Collaborative and the Skin Care in Organ Transplant Patients Europe. Reduction of immunosuppression for transplant-associated skin cancer: Expert consensus survey
    • Otley CC, Berg D, Ulrich C et al. Reduction of Immunosuppression Task Force of the International Transplant Skin Cancer Collaborative and The Skin Care in Organ Transplant Patients Europe. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 2006 154 : 395 400.
    • (2006) Br J Dermatol , vol.154 , pp. 395-400
    • Otley, C.C.1    Berg, D.2    Ulrich, C.3
  • 25
    • 0035880957 scopus 로고    scopus 로고
    • Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
    • Balch CM, Soong SJ, Gershenwald JE et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001 19 : 3622 34.
    • (2001) J Clin Oncol , vol.19 , pp. 3622-34
    • Balch, C.M.1    Soong, S.J.2    Gershenwald, J.E.3
  • 26
    • 0030040747 scopus 로고    scopus 로고
    • Malignant melanoma in organ allograft recipients
    • Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996 61 : 274 8.
    • (1996) Transplantation , vol.61 , pp. 274-8
    • Penn, I.1
  • 27
    • 0026773479 scopus 로고
    • Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selection
    • Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992 26 : 976 90.
    • (1992) J Am Acad Dermatol , vol.26 , pp. 976-90
    • Rowe, D.E.1    Carroll, R.J.2    Day Jr., C.L.3
  • 28
    • 0033853911 scopus 로고    scopus 로고
    • Post-transplant malignancy: The role of immunosuppression
    • Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf 2000 23 : 101 13.
    • (2000) Drug Saf , vol.23 , pp. 101-13
    • Penn, I.1
  • 30
    • 10744227990 scopus 로고    scopus 로고
    • Ten years of sirolimus therapy for human renal transplantation: The University of Texas at Houston experience
    • Kahan BD, Knight R, Schoenberg L et al. Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience. Transplant Proc 2003 35 (Suppl. 25S 34S.
    • (2003) Transplant Proc , vol.35
    • Kahan, B.D.1    Knight, R.2    Schoenberg, L.3
  • 31
    • 4043142865 scopus 로고    scopus 로고
    • Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: Results from five multicenter studies
    • Mathew T, Kries H, Friend P. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004 18 : 446 9.
    • (2004) Clin Transplant , vol.18 , pp. 446-9
    • Mathew, T.1    Kries, H.2    Friend, P.3
  • 32
    • 27644436740 scopus 로고    scopus 로고
    • Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
    • Kauffman HM, Cherikh WS, Cheng Y et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005 80 : 883 9.
    • (2005) Transplantation , vol.80 , pp. 883-9
    • Kauffman, H.M.1    Cherikh, W.S.2    Cheng, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.